Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Granger

Showing results (721-730 of 1,253) with videos related to

Pageof 126
Sort By:
Stroke|July 1, 2021
Reexamination of the Embolic Stroke of Undetermined Source ConceptGregory W Albers, Richard Bernstein, Johannes Brachmann, et al.
Clinical Trials (London, England)|February 20, 2008
Sensible approaches for reducing clinical trial costsEric L Eisenstein, Rory Collins, Beena S Cracknell, et al.
Journal of the American Heart Association|January 19, 2017
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE TrialPeter T Hu, Renato D Lopes, Susanna R Stevens, et al.
The American Journal of Cardiology|October 30, 2003
Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillationRajendra H Mehta, Omar H Dabbous, Christopher B Granger, et al.
American Heart Journal|June 20, 2012
A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN)Frans Van de Werf, Martina Brueckmann, Stuart J Connolly, et al.
European Heart Journal|March 4, 2008
Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to goKim A Eagle, Brahmajee K Nallamothu, Rajendra H Mehta, et al.
The American Journal of Emergency Medicine|September 14, 2024
Public access defibrillator locations and details in Forsyth County, North Carolina: Results of a telephone survey canvas of large businesses to facilitate out-of-hospital cardiac arrest treatmentJerishma Patel, Faraan O Rahim, Sreekanth Yellanki, et al.
JAMA|March 16, 2006
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trialSalim Yusuf, Shamir R Mehta, Susan Chrolavicius, et al.
Open Heart|May 11, 2023
Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysisLinda P T Joosten, Rosanne van Maanen, Carline J van den Dries, et al.
Journal of the American College of Cardiology|July 3, 2007
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke DatabankG Michael Felker, Larry A Allen, Stuart J Pocock, et al.
Pageof 126

Showing results (721-730 of 1,253) with videos related to

Sort By:
Pageof 126
Stroke|July 1, 2021
Reexamination of the Embolic Stroke of Undetermined Source ConceptGregory W Albers, Richard Bernstein, Johannes Brachmann, et al.
Clinical Trials (London, England)|February 20, 2008
Sensible approaches for reducing clinical trial costsEric L Eisenstein, Rory Collins, Beena S Cracknell, et al.
Journal of the American Heart Association|January 19, 2017
Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE TrialPeter T Hu, Renato D Lopes, Susanna R Stevens, et al.
The American Journal of Cardiology|October 30, 2003
Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillationRajendra H Mehta, Omar H Dabbous, Christopher B Granger, et al.
American Heart Journal|June 20, 2012
A comparison of dabigatran etexilate with warfarin in patients with mechanical heart valves: THE Randomized, phase II study to evaluate the safety and pharmacokinetics of oral dabigatran etexilate in patients after heart valve replacement (RE-ALIGN)Frans Van de Werf, Martina Brueckmann, Stuart J Connolly, et al.
European Heart Journal|March 4, 2008
Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to goKim A Eagle, Brahmajee K Nallamothu, Rajendra H Mehta, et al.
The American Journal of Emergency Medicine|September 14, 2024
Public access defibrillator locations and details in Forsyth County, North Carolina: Results of a telephone survey canvas of large businesses to facilitate out-of-hospital cardiac arrest treatmentJerishma Patel, Faraan O Rahim, Sreekanth Yellanki, et al.
JAMA|March 16, 2006
Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trialSalim Yusuf, Shamir R Mehta, Susan Chrolavicius, et al.
Open Heart|May 11, 2023
Clinical consequences of off-label reduced dosing of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a systematic review and meta-analysisLinda P T Joosten, Rosanne van Maanen, Carline J van den Dries, et al.
Journal of the American College of Cardiology|July 3, 2007
Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke DatabankG Michael Felker, Larry A Allen, Stuart J Pocock, et al.
Pageof 126